These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 27138574)

  • 1. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.
    Gupta C; Jongman M; Das S; Snehaa K; Bhattacharya SN; Seyedmousavi S; van Diepeningen AD
    Mycopathologia; 2016 Aug; 181(7-8):497-504. PubMed ID: 27138574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotyping of Fusarium Isolates from Onychomycoses in Colombia: Detection of Two New Species Within the Fusarium solani Species Complex and In Vitro Antifungal Susceptibility Testing.
    Guevara-Suarez M; Cano-Lira JF; de García MC; Sopo L; De Bedout C; Cano LE; García AM; Motta A; Amézquita A; Cárdenas M; Espinel-Ingroff A; Guarro J; Restrepo S; Celis A
    Mycopathologia; 2016 Apr; 181(3-4):165-74. PubMed ID: 26943726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phylogenetic Diversity and In Vitro Susceptibility Profiles of Human Pathogenic Members of the Fusarium fujikuroi Species Complex Isolated from South India.
    Tupaki-Sreepurna A; Thanneru V; Natarajan S; Sharma S; Gopi A; Sundaram M; Kindo AJ
    Mycopathologia; 2018 Jun; 183(3):529-540. PubMed ID: 29445920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of Fusarium infections in tropical dermatology evidenced by multilocus sequencing typing diagnostics.
    van Diepeningen AD; Feng P; Ahmed S; Sudhadham M; Bunyaratavej S; de Hoog GS
    Mycoses; 2015 Jan; 58(1):48-57. PubMed ID: 25530264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Genus Fusarium Causing Human Keratomycosis in South India.
    Hassan AS; Al-Hatmi AM; Shobana CS; van Diepeningen AD; Kredics L; Vágvölgyi C; Homa M; Meis JF; de Hoog GS; Narendran V; Manikandan P;
    Med Mycol; 2016 Mar; 54(3):287-94. PubMed ID: 26705832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex.
    Homa M; Shobana CS; Singh YR; Manikandan P; Selvam KP; Kredics L; Narendran V; Vágvölgyi C; Galgóczy L
    Mycoses; 2013 Sep; 56(5):501-11. PubMed ID: 23437826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant Fusarium in keratitis: a clinico-mycological study of keratitis infections in Chennai, India.
    Tupaki-Sreepurna A; Al-Hatmi AM; Kindo AJ; Sundaram M; de Hoog GS
    Mycoses; 2017 Apr; 60(4):230-233. PubMed ID: 27766684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum-equiseti species complexes from onychomycosis in north of Iran.
    Haghani I; Shams-Ghahfarokhi M; Dalimi Asl A; Shokohi T; Hedayati MT
    Mycoses; 2022 Nov; 65(11):1030-1039. PubMed ID: 35775829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility and multilocus sequence typing of Fusarium isolates causing keratitis.
    Dallé da Rosa P; Nunes A; Borges R; Batista B; Meneghello Fuentefria A; Goldani LZ
    J Mycol Med; 2018 Sep; 28(3):482-485. PubMed ID: 29779647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.
    Tortorano AM; Prigitano A; Esposto MC; Arsic Arsenijevic V; Kolarovic J; Ivanovic D; Paripovic L; Klingspor L; Nordøy I; Hamal P; Arikan Akdagli S; Ossi C; Grancini A; Cavanna C; Lo Cascio G; Scarparo C; Candoni A; Caira M; Drogari Apiranthitou M;
    Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1623-30. PubMed ID: 24791951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusarium metavorans sp. nov.: The frequent opportunist 'FSSC6'.
    Al-Hatmi AMS; Ahmed SA; van Diepeningen AD; Drogari-Apiranthitou M; Verweij PE; Meis JF; de Hoog GS
    Med Mycol; 2018 Apr; 56(suppl_1):144-152. PubMed ID: 29538734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
    Rosa PD; Heidrich D; Corrêa C; Scroferneker ML; Vettorato G; Fuentefria AM; Goldani LZ
    Mycoses; 2017 Sep; 60(9):616-622. PubMed ID: 28657120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological aspects and characterization of the resistance profile of
    Rosa PDD; Ramirez-Castrillon M; Borges R; Aquino V; Meneghello Fuentefria A; Zubaran Goldani L
    J Med Microbiol; 2019 Oct; 68(10):1489-1496. PubMed ID: 31419209
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergence of fusarioses in a university hospital in Turkey during a 20-year period.
    Dalyan Cilo B; Al-Hatmi AM; Seyedmousavi S; Rijs AJ; Verweij PE; Ener B; de Hoog GS; van Diepeningen AD
    Eur J Clin Microbiol Infect Dis; 2015 Aug; 34(8):1683-91. PubMed ID: 25994844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.
    Alastruey-Izquierdo A; Cuenca-Estrella M; Monzón A; Mellado E; Rodríguez-Tudela JL
    J Antimicrob Chemother; 2008 Apr; 61(4):805-9. PubMed ID: 18263569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex.
    O'Donnell K; Sutton DA; Fothergill A; McCarthy D; Rinaldi MG; Brandt ME; Zhang N; Geiser DM
    J Clin Microbiol; 2008 Aug; 46(8):2477-90. PubMed ID: 18524963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.
    Al-Hatmi AM; van Diepeningen AD; Curfs-Breuker I; de Hoog GS; Meis JF
    J Antimicrob Chemother; 2015 Apr; 70(4):1068-71. PubMed ID: 25538167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogenetic diversity of human pathogenic Fusarium and emergence of uncommon virulent species.
    Salah H; Al-Hatmi AM; Theelen B; Abukamar M; Hashim S; van Diepeningen AD; Lass-Florl C; Boekhout T; Almaslamani M; Taj-Aldeen SJ
    J Infect; 2015 Dec; 71(6):658-66. PubMed ID: 26348828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate and practical identification of 20 Fusarium species by seven-locus sequence analysis and reverse line blot hybridization, and an in vitro antifungal susceptibility study.
    Wang H; Xiao M; Kong F; Chen S; Dou HT; Sorrell T; Li RY; Xu YC
    J Clin Microbiol; 2011 May; 49(5):1890-8. PubMed ID: 21389150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phylogenetic Analysis of Clinically Relevant Fusarium Species in Iran.
    Najafzadeh MJ; Dolatabadi S; de Hoog S; Esfahani MK; Haghani I; Aghili SR; Ghazvini RD; Rezaei-Matehkolaei A; Abastabar M; Al-Hatmi AMS
    Mycopathologia; 2020 Jun; 185(3):515-525. PubMed ID: 32506392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.